Patent Baristas

Some days, you have to ask yourself if certain patent applications are filed purely for having them rejected and, in doing so, attempting to move back the line of just what is patenable.  Such it seems with the application at hand in In re Stephen w. Comiskey (06-1286).The U.S. Court of Appeals for the Federal […]

What:  Santa Clara Computer and High Technology Law Journal’s 25th Annual Symposium When: Friday, January 30, 2009 Where:  San Jose, Calif. Program: The 2009 Santa Clara Computer & High Technology Law Journal Symposium takes place in the heart of Silicon Valley, where innovation is happening every day. For years, the Journal has dedicated symposia to […]

Scott Shane, Ph.D., Professor of Economics at Case Western Reserve University, wrote up a detailed report on why the changes in the way damages are calculated in patent infringement lawsuits being asked for in various patent reform bills is wrong-headed. As reformers have proposed to change the method of calculating damages from a common-law methodology […]

Two new blogs are on the scene for keeping pace with biotechnology. OnBioVC OnBioVC, a new blog by veteran blogger Adam Rubenstein, is listed as “Your Source for BioScience Venture Capital Data.”  Headquartered in Boulder, Colorado, OnBioVC provides timely coverage and comprehensive analysis of global bioscience venture capital investment activity. Although heavy on the financial […]

Early stage valuation of drug development is complicated and often considered unnecessary given that standard valuation methods can lead to negative numbers.  Most early stage investors use the method known as “making it up” to value really early stage inventions. More than that, a large problem is that a company or university performing services early […]

In a search for the best of 2008 in the legal blogospshere, Blawg Review, is looking for which of the year’s 51 host presentations should be named the Blawg Review of the Year 2008.  We hosted Blawg Review #161 on Patent Baristas, the Memorial Day Edition of Blawg Review. There were many presentations this past […]

Last month, Abbott Laboratories was sued by Bayer AG’s HealthCare unit alleging that drugmaker Abbott Laboratories’ best-selling drug, the arthritis drug Humira, infringes on a Bayer patent.  (Bayer HealthCare LLC v. Abbott Laboratories, 08cv507, U.S. District Court for the Eastern District of Texas).  Bayer claims that Humira®, a recombinant human IgG1 monoclonal antibody specific for […]

Patents, trade secrets and confidentiality agreements are mere words on paper to the scientist, engineer or executive intent on deception and theft. And if you have outsourced your research and development efforts overseas to countries with unenforced intellectual property laws and cultural norms that ignore individual property rights, then the intent to deceive and thieve […]